Cellular models for personalised medicine were the last topic in the series of virtual working sessions focused on preclinical methods for personalised medicine, hosted on June 30th by WP5. A group of six expert users of cellular model systems for various human diseases discussed the challenges related to implementing peronalised medicine supported by this type of modelling. The advancement of organ-on-chip models bring the promise of personalised animal-free methods, but these biological models still need further development. Proposals for improving the current approach to developing new medicines, with an increased patient focus, included changing the existing pipeline, and funding clinical translation centres. The outcome of this meeting will be discussed further in a dedicated workshop titled “Recommendations for more robust and reproducible preclinical research in personalised medicine” scheduled for Wednesday, September 1st.
A new publication about robust & reproducible preclinical research in #PersonalisedMedicine has been published in BMCMedicine. Among the authors are EATRIS staff & institutions members. Congrats to all involved. 👉Find out more hereatris.eu/news/new-publi…w#PERMITprojectect https://t.co/kp46SdWB9G
New #PERMITProject publication: Recommendations for robust & reproducible preclinical research in personalised medicine. 15 recommendations are presented aiming to improve the robustness of preclinical methods in translational research for PM. permit-eu.org/publications https://t.co/zAS8pYOlOm